ElectraDx and TAUNS Laboratories Form Strategic Alliance to Deliver Next-Generation Point of Care Diagnostic Solutions
ElectraDx and TAUNS Laboratories announced a strategic capital and business alliance to co-develop and commercialise brand new diagnostic technologies that accelerate access to rapid, lab-quality testing for infectious and chronic diseases in Japan in point of care and home settings.
About ElectraDx
ElectraDx is transforming how and where people access diagnostic testing, with a company mission to 'Bring the lab to the heart of every community' and make lab-quality results available anytime, anywhere and to anyone, from clinics and community centres to the comfort of the home. This approach enables earlier diagnosis and intervention for chronic and acute conditions, removing barriers to testing and leading to better health outcomes and reduced healthcare costs.
Founded in 2023 by a leadership team with decades of experience in diagnostic innovation, including the development and launch of the first electrochemical home blood glucose monitors, digital pregnancy tests and point of care molecular systems, ElectraDx is shaping a new era of connected healthcare.
The company's innovative electrochemical based testing platform using proprietary microfluidic, protein and nucleic-acid detection technologies, combines speed, accuracy, connectivity and affordability to deliver results in under ten minutes from a simple finger-prick or swab. Using a low-cost platform, room-temperature test strips, which support simultaneous testing for multiple parameters with small sample volumes. This enables healthcare providers and patients to take faster, more informed action.
The versatile platform will ultimately offer a broad test menu including respiratory infections, STD's, diabetes and other chronic disease and inflammation markers.
Comments from the Executive
"We are very pleased to form this capital and business alliance with ElectraDx. This partnership will further accelerate the evolution and expansion of POCT, one of the key initiatives outlined in our medium-term management plan. We are confident that it will allow us to provide innovative POCT solutions that offer excellent performance, value for money and convenience."
— Masaki Nonaka, President and CEO, TAUNS Laboratories
"We are thrilled to partner with TAUNS Laboratories, a trusted leader in Japan's diagnostic industry with decades of expertise and proven innovation. We have enjoyed a long-standing relationship with Tauns and Nonaka-San and are excited to further strengthen this collaboration. TAUNS's deep understanding of the Japanese healthcare market and their long-standing commitment to quality make them the ideal partner to help bring ElectraDx's next-generation POCT technology to healthcare professionals and patients in Japan. We look forward to working closely together to accelerate access to fast, accurate, and affordable diagnostic solutions."
— Ron Zwanziger, Chairman and Founder, ElectraDx
For more information on TAUNS Laboratories, please visit: https://www.tauns.co.jp/en/